Table 1.

Classes of reported bacterial fatty acid synthesis (FASII) inhibitors.

Inhibitor Class	Target Bacteria	References
Diazaborines	E. coli, S. aureus	[68]
1,2,3,4-tetrahydro-1H-pyrido [3,4-b]indole derivatives	S. aureus, Enterococcus faecalis	[69]
1H-imidazole derivatives	S. aureus, E. coli	[70]
Diphenyl ethers and triclosan analogs	E. coli, M. tuberculosis	[71]
Naphthyridinones	S. aureus, S. pneumoniae	[69]
Acrylamide-based compounds	M. tuberculosis	[72]
1,5,6,7-tetrahydroindeno [5,6-d]imidazoles	M. tuberculosis	[73]
Coumarin derivatives	M. tuberculosis, S. aureus	[74]
Pyrone/pyridone derivatives	M. tuberculosis	[75]
Pyrrolidine-based inhibitors	P. aeruginosa	[76]
Quinoline/quinoxaline derivatives	M. tuberculosis	[77]
N′-benzoylbenzohydrazides	M. tuberculosis	[78]